2024/53/B/NZ7/00220
Keywords:
Semaglutide GLP-1 analogs obesity drug misuse weight loss efectiveness and safety of therapy
Descriptors:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi
woj. łódzkie
Principal investigator (from the host institution):
dr hab. Jakub Łukasz Wojcieszak
Number of co-investigators in the project: 10
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 2 053 882 PLN
Project start date (Y-m-d): 2025-06-02
Project end date (Y-m-d): 2029-06-01
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.